Market Research Logo

Global Next Generation Sequencing Market 2015-2019

Global Next Generation Sequencing Market 2015-2019

About NGS

Next generation sequencing (NGS) technology is used to sequence millions of small fragments of DNA simultaneously. The technology is similar to capillary electrophoresis where the bases of small fragments of DNA are sequentially identified from signals emitted, and each fragment is resynthesized from a DNA template strand. The major difference is that NGS process is extended across millions of reactions in a massively parallel fashion, rather than restricted to a single or a few DNA fragments. This technology enables rapid sequencing of large stretches of DNA base pairs spanning entire genomes with highly sophisticated instruments capable of producing hundreds of gigabytes of data in a single sequencing run. NGS finds application in whole genome, exome, and transcriptome sequencing that provide a high-resolution and global view of various applications such as the cancer genome. NGS coupled with bioinformatics tools has revolutionized cancer research, diagnosis, and therapy. This technology helps to track and trace the spread of disease and foreign contaminants in drugs.

Technavio's analysts forecast the global next generation sequencing market to grow at a CAGR of 21.36% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global next generation sequencing market for the period 2015-2019. The global next generation sequencing market is divided into two segments: equipment, and reagents and consumables. To calculate the market size, the report considers the revenue generated from the sales of equipment, and reagents and consumables used in next generation sequencing in the following customer segments:

  • Commercial entities such as hospitals and pharmaceutical and life sciences companies
  • Research institutes
Technavio's report, Global Next Generation Sequencing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.Key Regions
  • Americas
  • APAC
  • EMEA
Key Vendors
  • Illumina
  • Roche Diagnostics
  • Thermo Fischer Scientific
Other Prominent Vendors
  • 10X Genomics
  • 23andMe
  • Ambry Genetics
  • Axeq Technologies
  • Beijing Genomics Institute
  • CLC bio
  • Clontech Laboratories
  • Fluidigm
  • Foundation Medicine
  • GATC Biotech
  • GeneDx
  • GENEWIZ
  • Gnomegen
  • Good Start Genetics
  • Ingenuity Systems
  • Knome
  • NABsys
  • Oxford Nanopore Technologies
  • Pathogenica
  • PerkinElmer
  • RainDance Technologies
  • Rubicon Genomics
  • Sequenom
  • Sigma-Aldrich
  • Source Biosciences
  • Takara Bio
  • Market Driver
  • Increased Adoption by New Customers
  • For a full, detailed list, view our report
  • Market Challenge
  • Technical and Implementation Issues
  • For a full, detailed list, view our report
  • Market Trend
  • Strategic Alliances
  • For a full, detailed list, view our report
Key Questions Answered in this Report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Next Generation Sequencing Market 2015-2019

Technavio recognizes the following companies as the key players in Global Next Generation Sequencing Market 2015-2019: Illumina, Roche Diagnostics and Thermo Fischer Scientific

Other Prominent Vendors in the market are: 10X Genomic, 23andMe, Ambry Genetics, Axeq Technologies, Beijing Genomics Institute, CLC bio, Clontech Laboratories, Fluidigm, Foundation Medicine, GATC Biotech, GeneDx, GENEWIZ, Gnomegen, Good Start Genetics, Ingenuity Systems, Knome, NABsys, Oxford Nanopore Technologies, Pathogenica, PerkinElmer, RainDance Technologies, Rubicon Genomics, Sequenom, Sigma-Aldrich, Source Biosciences and Takara Bio

Commenting on the report, an analyst from Technavio’s team said: “One of the major trend in this market is strategic alliances between large corporations and specialized companies for enhancing their business in genomic sequencing. For instance, in 2014 Thermo Fisher Scientific collaborated with Pfizer and GSK to develop oncology companion diagnostics using NGS technology. These alliances enhance the expertise in DNA sequencing and accelerate drug discovery efforts.”

According to the report, one of the major factors expected to drive the market is advances in applications of NGS in molecular biology and biomedical engineering. The evolution of NGS technology as a molecular microscope has created interest among researchers, hospitals, and pharmaceutical and life sciences companies in finding solutions for complex biological questions.

Further, the report states that one of the challenge is the lack of standardization in data analysis.

Companies Mentioned

Illumina, Roche Diagnostics, Thermo Fischer Scientific, 10X Genomic, 23andMe, Ambry Genetics, Axeq Technologies, Beijing Genomics Institute, CLC bio, Clontech Laboratories, Fluidigm, Foundation Medicine, GATC Biotech, GeneDx, GENEWIZ, Gnomegen, Good Start Genetics, Ingenuity Systems, Knome, NABsys, Oxford Nanopore Technologies, Pathogenica, PerkinElmer, RainDance Technologies, Rubicon Genomics, Sequenom, Sigma-Aldrich, Source Biosciences, Takara Bio

  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Market Overview
    • Product Offerings
  • Market Research Methodology
    • Market Research Process
    • Research Methodology
      • Table Market Research Methodology
  • Introduction
  • Market Landscape
    • Market Overview
    • Market Size and Forecast
      • Table Global NGS Market 2014-2019 ($ million)
    • Five Forces Analysis
  • Genome Sequencing Cost Analysis
    • Table Cost per Genome 2001-2014 ($ million)
    • Table Cost per Megabase of DNA Sequence 2001-2014 ($)
  • Cost of Equipment
    • Table Estimated Cost of NGS Equipment
  • Reimbursement and Coverage
  • Regulatory Point of View for NGS Tests
    • Analytical Performance of NGS Tests
    • Accessing Clinical Performance of NGS Tests
      • Leveraging Genetic Databases to Evaluate Clinical Performance
      • Communicate Information about Less Well-known Variants
  • Market Segmentation by Product
    • Global NGS Market by Product 2014-2019
      • Table Global NGS Market by Product 2014
      • Table Global NGS Market by Product 2019
      • Table Global NGS Market by Product 2014-2019
    • Global NGS Market by Reagents and Consumables
      • Market Size and Forecast
        • Table Global NGS Market by Reagents and Consumables 2014-2019 ($ million)
    • Global NGS Market by Equipment
      • Market Size and Forecast
        • Table Global NGS Market by Equipment 2014-2019 ($ million)
  • Market Segmentation by End-user
    • Global NGS Market by End-user 2014-2019
      • Table Global NGS Market by End-user 2014
  • Market Segmentation by Technology
    • Global NGS Market by Technology
      • Sequencing by Synthesis
      • Ion Semiconductor Sequencing
      • Sequencing by Ligation
      • Pyrosequencing
      • SMRT Sequencing
  • Geographical Segmentation
    • Global NGS Market by Geographical Segmentation 2014-2019
      • Table Global NGS Market by Geographical Segmentation 2014
      • Table Global NGS Market by Geographical Segmentation 2019
      • Table Global NGS Market by Geographical Segmentation 2014-2019
    • NGS Market in Americas
      • Market Size and Forecast
        • Table NGS Market in Americas 2014-2019 ($ million)
    • NGS Market in EMEA
      • Market Size and Forecast
        • Table NGS Market in EMEA 2014-2019 ($ million)
    • NGS Market in APAC
      • Market Size and Forecast
        • Table NGS Market in APAC 2014-2019 ($ million)
  • Buying Criteria
  • Market Growth Drivers
  • Drivers and their Impact
  • Market Challenges
  • Impact of Drivers and Challenges
  • Market Trends
  • Trends and their Impact
  • Vendor Landscape
    • Competitive Scenario
      • Key News
      • Mergers and Acquisitions
    • Market Share Analysis 2014
      • Table Market Share Analysis 2014
    • Other Prominent Vendors
  • Key Vendor Analysis
    • Illumina
      • Key Facts
      • Business Overview
      • Business Segmentation
        • Table Illumina: Business Segmentation
      • Geographical Segmentation by Revenue 2013
        • Table Illumina: Geographical Segmentation by Revenue 2013
      • Business Strategy
      • Key Information
      • SWOT Analysis
    • Roche Diagnostics
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table Roche Diagnostics: Business Segmentation by Revenue 2013
      • Geographical Segmentation by Revenue 2013
        • Table Roche Diagnostics: Geographical Segmentation by Revenue 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
    • Life Technologies now part of Thermo Fisher Scientific
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2012
        • Table Life Technologies: Business Segmentation by Revenue 2012
      • Geographical Segmentation by Revenue 2012
        • Table Life Technologies: Geographical Segmentation by Revenue 2012
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
  • Other Reports in this Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report